carcinoma in situ


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to carcinoma in situ: squamous cell carcinoma

carcinoma in situ

[‚kärs·ən′ō·mə in ′si·chü]
(medicine)
A malignant tumor in the premetastatic stage, when cells are at the site of origin.
References in periodicals archive ?
Lobular carcinoma in situ and ALH have been well-established as risk factors for the development of invasive breast carcinoma.
Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery.
Myong (11) reported that normal control tissues exhibited almost no vimentin immunohistochemical expression, and carcinoma in situ lesions showed 8.
Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.
Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma," Breast Journal, vol.
Ductal carcinoma in situ is confined entirely to the ductal system of the breast.
Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases.
Incidence of and treatment for ductai carcinoma in situ of the breast.
In addition, this Multiplex IHC test is particularly useful to reduce false negatives and false positives for microinvasion; when there are overlapping features of lobular carcinoma in situ and ductal carcinoma in situ in a lesion; when there is necrosis potentially masking microinvasion; to differentiate higher nuclear grade LCIS patients such as pleomorphic lobular carcinoma in situ which may mimic DCIS; and in LCIS samples where LCIS cells grow into a duct, or the lobule becomes distended so that its appearance is similar to a duct, making the differentiation of LCIS and DCIS more challenging.
Patients with carcinoma in situ had higher rates of reoperation because their tumors were multifocal and more difficult than usual to locate preoperatively.
La adenosis esclerosante se puede asociar y presentar con otras lesiones proliferativas benignas, como papiloma intraductal y/o esclerosante, lesion esclerosante compleja, fibroadenomas, entre otras, asimismo puede coexistir con lesiones invasoras o carcinoma in situ.